Low dose of Pfizer-BioNTech vaccine is safe and effective in children ages 5 to 11, companies’ study finds – The Washington Post September 19, 2021 by quixnet Low dose of Pfizer-BioNTech vaccine is safe and effective in children ages 5 to 11, companies’ study findsThe Washington Post